{"title":"牛奶过敏儿童的患者特征表现为对作为消除饮食一部分的广泛水解乳清和/或酪蛋白配方过敏","authors":"Z. Nowacki","doi":"10.5114/PDIA.2012.32389","DOIUrl":null,"url":null,"abstract":"Introduction: In the recent years the number of children with cow’s milk protein allergy (CMPA) presenting with aller gies to extensively hydrolyzed whey (eHF-W) and casein formulae (eHF-C) respectively has increased. Aim: To present the patient characteristics of children with CMPA who presented with allergic reactions to eHF-W and/or eHF-C used as part of an elimination diet. Material and methods: A retrospective study was carried out for a group of 65 selected from of 359 children (3 to 12 months) affected with CMPA and allergy to eHF. Results: 18.1% (65/359) and 7.8% (28/359) from the group presented with allergic reactions to eHF-W and eHF-C, respectively. An allergic reaction to eHF-C occurred in 43% of the patients from the group (28/65). IgE-mediated CMPA presented with one of the following clinical manifestations: atopic dermatitis (AD) 94%, gastrointestinal symptoms (GI) 47%, respiratory symptoms (RS) 44%, anaphylactic reactions (AR) 26%. Non-IgE-mediated CMPA, on the other hand, manifested with: AD 97%, GI 22%, RS 10% .The observations showed that all 31 from the non-IgE mediated CMPA group with GI and AD manifestations presented with symptoms of eHF-C allergy ( p = 0.001). In the IgE-medi ated CMPA ( n = 34) the following factors were statistically significant with relation to eHF-C allergy: CMPA mani festing with GI ( p = 0.014) and AD. The occurrence of AR in response to cow’s milk protein (CMP) decreased the prob ability of an eHF-C allergy ( p = 0.028) in a statistically significant way. Conclusions: Children with CMPA who presented with allergies to eHF-W and eHF-C had a higher frequency of clin ical manifestation with GI and AD.","PeriodicalId":7212,"journal":{"name":"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Original paper Patient characteristics of children with cow’s milk allergy presenting with an allergy to extensively hydrolyzed whey and/or casein formulae used as part of an elimination diet\",\"authors\":\"Z. Nowacki\",\"doi\":\"10.5114/PDIA.2012.32389\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: In the recent years the number of children with cow’s milk protein allergy (CMPA) presenting with aller gies to extensively hydrolyzed whey (eHF-W) and casein formulae (eHF-C) respectively has increased. Aim: To present the patient characteristics of children with CMPA who presented with allergic reactions to eHF-W and/or eHF-C used as part of an elimination diet. Material and methods: A retrospective study was carried out for a group of 65 selected from of 359 children (3 to 12 months) affected with CMPA and allergy to eHF. Results: 18.1% (65/359) and 7.8% (28/359) from the group presented with allergic reactions to eHF-W and eHF-C, respectively. An allergic reaction to eHF-C occurred in 43% of the patients from the group (28/65). IgE-mediated CMPA presented with one of the following clinical manifestations: atopic dermatitis (AD) 94%, gastrointestinal symptoms (GI) 47%, respiratory symptoms (RS) 44%, anaphylactic reactions (AR) 26%. Non-IgE-mediated CMPA, on the other hand, manifested with: AD 97%, GI 22%, RS 10% .The observations showed that all 31 from the non-IgE mediated CMPA group with GI and AD manifestations presented with symptoms of eHF-C allergy ( p = 0.001). In the IgE-medi ated CMPA ( n = 34) the following factors were statistically significant with relation to eHF-C allergy: CMPA mani festing with GI ( p = 0.014) and AD. The occurrence of AR in response to cow’s milk protein (CMP) decreased the prob ability of an eHF-C allergy ( p = 0.028) in a statistically significant way. Conclusions: Children with CMPA who presented with allergies to eHF-W and eHF-C had a higher frequency of clin ical manifestation with GI and AD.\",\"PeriodicalId\":7212,\"journal\":{\"name\":\"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/PDIA.2012.32389\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/PDIA.2012.32389","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Original paper Patient characteristics of children with cow’s milk allergy presenting with an allergy to extensively hydrolyzed whey and/or casein formulae used as part of an elimination diet
Introduction: In the recent years the number of children with cow’s milk protein allergy (CMPA) presenting with aller gies to extensively hydrolyzed whey (eHF-W) and casein formulae (eHF-C) respectively has increased. Aim: To present the patient characteristics of children with CMPA who presented with allergic reactions to eHF-W and/or eHF-C used as part of an elimination diet. Material and methods: A retrospective study was carried out for a group of 65 selected from of 359 children (3 to 12 months) affected with CMPA and allergy to eHF. Results: 18.1% (65/359) and 7.8% (28/359) from the group presented with allergic reactions to eHF-W and eHF-C, respectively. An allergic reaction to eHF-C occurred in 43% of the patients from the group (28/65). IgE-mediated CMPA presented with one of the following clinical manifestations: atopic dermatitis (AD) 94%, gastrointestinal symptoms (GI) 47%, respiratory symptoms (RS) 44%, anaphylactic reactions (AR) 26%. Non-IgE-mediated CMPA, on the other hand, manifested with: AD 97%, GI 22%, RS 10% .The observations showed that all 31 from the non-IgE mediated CMPA group with GI and AD manifestations presented with symptoms of eHF-C allergy ( p = 0.001). In the IgE-medi ated CMPA ( n = 34) the following factors were statistically significant with relation to eHF-C allergy: CMPA mani festing with GI ( p = 0.014) and AD. The occurrence of AR in response to cow’s milk protein (CMP) decreased the prob ability of an eHF-C allergy ( p = 0.028) in a statistically significant way. Conclusions: Children with CMPA who presented with allergies to eHF-W and eHF-C had a higher frequency of clin ical manifestation with GI and AD.